Suscribirse

HERBAL AND ALTERNATIVE MEDICINE - 05/09/11

Doi : 10.1016/S0733-8627(05)70154-1 
Lewis Nelson, MD a, Jeanmarie Perrone, MD b
a Medical Toxicology Fellowship, New York City Poison Control Center; the Division of Emergency Medicine, Department of Surgery, Bellevue Hospital Center of New York University, New York, New York (LN) 
b Division of Toxicology, Department of Emergency Medicine, University of Pennsylvania School of Medicine; and the Department of Emergency Medicine, The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (JP) 

Resumen

The use of “unconventional” or “alternative” medicine by the American public is now commonplace. In 1998, the alternative medicines industry accounted for $8.1 billion in economic impact. The prevalence of alternative medicine use in several US surveys ranges from 10% to 40% and is growing rapidly.18, 25, 46 In the most recent of these surveys, the use of alternative therapies increased through the 1990s, led especially by the growth of herbal medicines, megavitamins and folk remedies.18 This trend is expected to continue because some insurance providers and health systems are now advertising coverage of certain alternative regimens.48 Emergency physicians must be aware of alternative medicine and its various disciplines, because a significant proportion of ED patients report their use.25

Alternative medicine is a general term referring to a heterogenous set of therapies not taught in conventional medical schools in the United States; however, even this definition is outdated. In a 1998 study, 75 US medical schools described courses in alternative medicine.59 Alternative medical therapy includes the use of dietary supplements, vitamins, minerals, hormones, proteins, and botanicals such as herbals. Although herbs are defined botanically as a specific subgroup of plants, herbal supplements are loosely conceived of as any plant containing or plant-derived product. These are perceived to be more natural or “safer” than are conventional medications and appeal to many people, especially patients with chronic diseases. Unfortunately, few patients realize the lack of scrutiny or testing that these products undergo.

Because these products are considered neither food nor drug, they escape the jurisdiction of the Food and Drug Administration (FDA) and thus are held to minimal standards. In addition to potential endogenous toxicity of the product used, additional toxicity can result from drug interactions41 or by contamination of product with other botanicals26, 55 or heavy metals.20, 37 When critically reviewed, a small number of these therapies could have some efficacy,61 but some have been associated with distinct toxic syndromes and can be encountered in the ED patient. Although alternative medicine also includes a gamut of nonmedicinal-based ideologies such as yoga, therapeutic touch, and massage, this review focuses on ingested products such as herbals, minerals, and dietary supplements.

Multiple cases of toxicity highlight the need for regulation of these products; however, the economic lobby opposing FDA regulation led to the Dietary Supplement and Health Education Act of 1994. This law created a new category, including vitamins, minerals, herbs, and amino acids and is virtually free of FDA regulations. Fortunately, the Office of Alternative Medicine within the National Institute of Health (NIH) is funding more appropriate investigations of the possible efficacy or harm of these therapies, albeit on a limited budget.38 Emergency physicians could witness sentinel toxic events and should be reminded to report these events to Poison Centers and the FDA MedWatch program, to catalogue toxicity data from these products.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Lewis Nelson, MD, New York City Poison Control Center, 455 First Avenue, Room 123, New York, NY 10016, e-mail: nycpcc@hotmail.com


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 18 - N° 4

P. 709-722 - novembre 2000 Regresar al número
Artículo precedente Artículo precedente
  • THE NEW ANTIBIOTICS
  • Diane Birnbaumer, Madonna Fernández-Frackelton
| Artículo siguiente Artículo siguiente
  • ADVANCES IN THE PHARMACOLOGY OF ACUTE CORONARY SYNDROME : Platelet Inhibition
  • Brian R. Tiffany, Robert Barrali

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.